Smad2 mediates transforming growth factor-β induction of endothelial nitric oxide synthase expression

74Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Transforming growth factor-β (TGF-β) increases expression of endothelial nitric oxide synthase (eNOS), although the precise mechanism by which it does so is unclear. We report that Smad2, a transcription factor activated by TGF-β, mediates TGF-β induction of eNOS in endothelial cells. TGF-β induces Smad2 translocation from cytoplasm to nucleus, where it directly interacts with a specific region of the eNOS promoter. Overexpression of Smad2 increases basal levels of eNOS, and further increases TGF-β stimulation of eNOS expression. Ectopic expression of Smurf, an antagonizer of Smad2, decreases Smad2 expression and blocks TGF-β induction of eNOS. Because Smad2 can interact with a variety of transcription factors, coactivators, and corepressors, Smad2 may thus act as an integrator of multiple signals in the regulation of eNOS expression.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Saura, M., Zaragoza, C., Cao, W., Bao, C., Rodríguez-Puyol, M., Rodríguez-Puyol, D., & Lowenstein, C. J. (2002). Smad2 mediates transforming growth factor-β induction of endothelial nitric oxide synthase expression. Circulation Research, 91(9), 806–813. https://doi.org/10.1161/01.RES.0000040397.23817.E5

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

44%

Professor / Associate Prof. 5

28%

Researcher 5

28%

Readers' Discipline

Tooltip

Medicine and Dentistry 9

43%

Agricultural and Biological Sciences 7

33%

Biochemistry, Genetics and Molecular Bi... 4

19%

Pharmacology, Toxicology and Pharmaceut... 1

5%

Save time finding and organizing research with Mendeley

Sign up for free